SS-31 50 mg: Advanced Mitochondrial Protection for Enhanced Performance and Recovery
Dragon Pharma introduces SS-31 50 mg, a revolutionary mitochondrial-targeted peptide that represents a breakthrough in cellular protection and energy optimization research. Also known as Elamipretide, this innovative compound specifically targets and protects mitochondria from oxidative damage, making it invaluable for studying exercise performance, recovery enhancement, and age-related mitochondrial decline. With its unique ability to cross multiple biological barriers and accumulate within mitochondria, SS-31 offers researchers unprecedented opportunities to study cellular energy production, oxidative stress management, and overall mitochondrial health. For bodybuilders and athletes, Dragon Pharma SS-31 provides a sophisticated research tool for optimizing cellular function and enhancing recovery from intense training.
DRUG DESCRIPTION
Dragon Pharma’s SS-31 is supplied as a high-purity, sterile lyophilized powder in a 50 mg / 2 mL vial. SS-31 (Elamipretide) is a novel tetra-peptide (D-Arg-DimethylTyr-Lys-Phe-NH2) that features a unique structural motif allowing it to selectively target and penetrate mitochondrial membranes. The peptide’s mechanism of action centers on its interaction with cardiolipin, an essential phospholipid located exclusively in the inner mitochondrial membrane. SS-31 binds to cardiolipin and helps maintain its optimal structural configuration, which is crucial for proper function of the electron transport chain and prevention of cytochrome c release. By stabilizing cardiolipin, SS-31 enhances mitochondrial efficiency, reduces electron leakage and reactive oxygen species (ROS) production, improves ATP synthesis, and prevents mitochondrial membrane permeabilization that can trigger apoptosis. This targeted approach makes SS-31 particularly valuable for researching conditions involving mitochondrial dysfunction and oxidative stress.
SS-31 PROFILE
Drug Class: Mitochondrial Peptide
Main Active Substance: SS-31
Concentration: 50 mg/vial
Presentation: 2 mL Vial
Elimination Half-Life: ~2-4 hours
Recommended Dosage: 20-40 mg daily
Anabolic Ratio: N/A
Androgenic Ratio: N/A
Acne: No
Hepatotoxicity: No
Aromatization: No
Manufacturer: Dragon Pharma
HOW TO USE SS-31
For research purposes, SS-31 50 mg is reconstituted with bacteriostatic water. Research protocols typically involve subcutaneous administration, with dosing frequency ranging from daily to several times per week depending on research objectives. Common research doses range from 2-8 mg daily, with many protocols utilizing divided dosing to maintain consistent mitochondrial protection. Research cycles typically last 4-12 weeks to observe significant improvements in mitochondrial function and oxidative stress markers. SS-31 is frequently researched as part of comprehensive mitochondrial optimization and recovery stacks. It combines powerfully with NAD+ for enhanced cellular energy production and mitochondrial protection research. For exercise performance studies, it pairs effectively with Aicar 50 mg to optimize metabolic efficiency and endurance capacity. During intense training cycles with compounds like Trenbolone 100, SS-31 provides essential mitochondrial protection against exercise-induced oxidative stress. For comprehensive anti-aging research, it can be stacked with Epitalon 50 mg to address multiple aspects of cellular aging. For recovery enhancement, it pairs well with BPC-157 for comprehensive tissue repair and cellular protection.
POSSIBLE SIDE EFFECTS
SS-31 is exceptionally well-tolerated in research settings, with an excellent safety profile demonstrated in numerous clinical and preclinical studies. The most common effects are limited to mild injection site reactions such as temporary redness or discomfort. Some research subjects report transient improvements in energy levels and exercise tolerance, which are consistent with enhanced mitochondrial function. Unlike many research compounds, SS-31 does not cause gastrointestinal distress, hormonal disruption, or significant systemic side effects. There is no risk of organ toxicity or dependency with proper dosing. The peptide’s mitochondrial-targeted mechanism means it works specifically within cellular powerhouses without disrupting other physiological processes. Its antioxidant properties may actually reduce existing oxidative stress rather than creating new adverse reactions. The high concentration of 50 mg per vial allows for flexible dosing across various research scenarios while maintaining convenience and cost-effectiveness.
CONCLUSION
Dragon Pharma’s SS-31 50 mg represents a sophisticated approach to mitochondrial research, offering targeted protection and optimization of cellular energy production systems. Its unique cardiolipin-binding mechanism makes it particularly valuable for studying exercise-induced oxidative stress, age-related mitochondrial decline, and conditions involving impaired cellular energy production. Unlike broad-spectrum antioxidants, SS-31 works specifically within mitochondria where the majority of cellular ROS is generated, making it highly efficient for research into oxidative stress management. When implemented within structured research protocols that account for its mitochondrial-targeted effects and include appropriate cellular monitoring, SS-31 can yield significant insights into exercise performance optimization, recovery acceleration, and overall cellular health maintenance. For researchers exploring the frontiers of mitochondrial medicine, exercise physiology, and healthy aging, Dragon Pharma SS-31 provides a precise, effective tool for groundbreaking studies in cellular energy optimization.
SS-31 FAQ
Unlike conventional antioxidants that work throughout the body, SS-31 specifically targets and accumulates within mitochondria where most cellular oxidative damage occurs. This targeted approach makes it significantly more efficient for researching mitochondrial protection, as it addresses oxidative stress at its primary source rather than providing general systemic antioxidant effects.
Yes, by protecting mitochondria from exercise-induced oxidative damage, SS-31 may help maintain mitochondrial efficiency during intense training, potentially enhancing endurance capacity and accelerating recovery between training sessions. Research suggests it may be particularly valuable for studying high-intensity exercise and overtraining syndromes.
Initial effects on cellular energy parameters and oxidative stress markers can often be detected within 2-4 weeks, with significant improvements in mitochondrial function typically observed after 6-12 weeks of consistent administration in research settings. The timing varies based on the specific research model and dosing protocol.
Absolutely. Mitochondrial dysfunction is a hallmark of aging, and SS-31’s ability to protect and optimize mitochondrial function makes it particularly valuable for researching age-related cellular decline, decreased exercise tolerance, and reduced recovery capacity associated with advancing age.
The 50 mg concentration provides flexibility for various dosing strategies, from low-dose preventive studies to higher-dose therapeutic applications. The larger vial size reduces reconstitution frequency and ensures consistent dosing across extended research periods, making it cost-effective for long-term mitochondrial studies. For scientific context, see: National Library of Medicine – Mitochondrial Function.